In the afternoon of October 2, 2016, Professor Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University, met with Dr. Henry (Hongjun) Ji (Chief Executive Officer of Sorrento Therapeutics, Inc., NASDAQ: SRNE), Dr. Dongliang Ge (President of BioScikin Co., Ltd., Nanjing) and Mr. Guowei Dong (Assistant to the Chairman of Simcere Pharmaceutical Group, Nanjing) at San Diego, California (U.S.A.). They discussed the proposition of establishing an innovation fund in an academic setting based in Zhangjiang High-Tech Park.